Phase 2 Trial of Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma(PCNSL), and Other Extra-Nodal Diffuse Large B-cell Lymphomas
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications B cell lymphoma; Cutaneous B-cell lymphoma; Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 12 Dec 2017 Planned initiation date changed from 1 Dec 2017 to 18 Dec 2017.
- 25 Nov 2017 Planned initiation date changed from 30 Nov 2017 to 1 Dec 2017.
- 24 Nov 2017 Planned initiation date changed from 1 Nov 2017 to 30 Nov 2017.